We are live on ! Find out more
BNP Paribas Financial Markets

BNP Paribas Financial Markets Portfolio holdings

AUM $289B
1-Year Est. Return 60.46%
 

BNP Paribas Financial Markets, a core component of BNP Paribas’s Corporate & Institutional Banking (CIB) division, is a global leader in trading and market-making, headquartered in Paris with major hubs in London, New York, Hong Kong, and Singapore. Specializing in derivatives across all asset classes—equities, fixed income, commodities, and foreign exchange—it provides innovative investment, hedging, and financing solutions to corporate clients, institutional investors, and financial institutions worldwide. Known for its advanced technological infrastructure and quantitative expertise, the division excels in structured financing and electronic trading, supported by a robust balance sheet and a diversified business model that proved resilient during the 2008 financial crisis. With a presence in over 50 countries and a client base exceeding 13,000, BNP Paribas Financial Markets drives market liquidity and offers cutting-edge research and execution services, reinforcing its position as a top-tier player in global capital markets.

This Fund
S&P 500
This Quarter Est. Return
+7.26%
1 Year Est. Return
+60.46%
3 Year Est. Return
+148.24%
5 Year Est. Return
+163.86%
10 Year Est. Return
+570.16%
AUM
$80B
AUM Growth
+$8.59B
Cap. Flow
+$503M
Cap. Flow %
0.63%
Top 10 Hldgs %
21.05%
Holding
4,079
New
263
Increased
1,328
Reduced
1,932
Closed
164

Sector Composition

Rank Sector Weight
1 Technology 14.29%
2 Consumer Discretionary 8.84%
3 Healthcare 6.65%
4 Financials 5.52%
5 Industrials 3.81%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ESSA
3426
DELISTED
ESSA Bancorp
ESSA
$33.7K ﹤0.01%
+2,256
New +$34K
MACK
3427
DELISTED
Merrimack Pharmaceuticals, Inc.
MACK
$33.5K ﹤0.01%
+2,726
New +$34.1K
ACIC icon
3428
American Coastal Insurance
ACIC
$461M
$33.3K ﹤0.01%
7,456
+6,802
+1,040% +$29.4K
CUE icon
3429
Cue Biopharma
CUE
$131M
$33.2K ﹤0.01%
303
+300
+10,000% +$35.3K
IVAC
3430
DELISTED
Intevac Inc
IVAC
$33.1K ﹤0.01%
+8,829
New +$47.3K
CLPR
3431
Clipper Realty
CLPR
$53M
$31.8K ﹤0.01%
5,602
+2,903
+108% +$15.8K
NKGNW
3432
DELISTED
NKGen Biotech, Inc. Warrants
NKGNW
$31.4K ﹤0.01%
150,000
ITM icon
3433
VanEck Intermediate Muni ETF
ITM
$2.14B
$31.4K ﹤0.01%
+681
New +$31.4K
MIST icon
3434
Milestone Pharmaceuticals
MIST
$133M
$30.8K ﹤0.01%
10,810
+8,659
+403% +$32.7K
AILEW
3435
DELISTED
iLearningEngines, Inc. Warrant
AILEW
$30.8K ﹤0.01%
134,386
PLSE icon
3436
Pulse Biosciences
PLSE
$3.2B
$30.2K ﹤0.01%
4,199
+3,683
+714% +$23.5K
PBR.A icon
3437
Petrobras Class A
PBR.A
$104B
$29.5K ﹤0.01%
2,381
-444
-16% -$4.84K
TELL
3438
DELISTED
Tellurian Inc.
TELL
$28.6K ﹤0.01%
20,301
-184,758
-90% -$248K
PSX icon
3439
CALL
Phillips 66
PSX
$92.8B
$28.6K ﹤0.01%
3
EVGN icon
3440
Evogene
EVGN
$10.3M
$28.6K ﹤0.01%
2,670
+1,939
+265% +$13.1K
TLH icon
3441
iShares 10-20 Year Treasury Bond ETF
TLH
$10.9B
$28.4K ﹤0.01%
+256
New +$28.7K
INSG icon
3442
Inseego
INSG
$77.7M
$28K ﹤0.01%
4,349
-6,737
-61% -$53.9K
RAD
3443
DELISTED
Rite Aid Corporation
RAD
$28K ﹤0.01%
18,535
-36,990
-67% -$74.1K
LBC
3444
DELISTED
Luther Burbank Corporation Common Stock
LBC
$27.3K ﹤0.01%
3,065
+49
+2% +$444
TCRT icon
3445
Alaunos Therapeutics
TCRT
$4.86M
$27.1K ﹤0.01%
355
+62
+21% +$5.02K
TCI icon
3446
Transcontinental Realty Investors
TCI
$312M
$26.7K ﹤0.01%
730
-2,132
-74% -$79.2K
UONEK icon
3447
Urban One Class D
UONEK
$24.1M
$26K ﹤0.01%
433
-265
-38% -$15.1K
TRVI icon
3448
Trevi Therapeutics
TRVI
$2.59B
$25.9K ﹤0.01%
+10,849
New +$27.3K
VWOB icon
3449
Vanguard Emerging Markets Government Bond ETF
VWOB
$6.25B
$25K ﹤0.01%
+402
New +$24.7K
SCPL
3450
DELISTED
SciPlay Corporation Class A Common Stock
SCPL
$25K ﹤0.01%
1,268
-28,724
-96% -$522K

Similar funds

BNP Paribas Financial Markets's Q2 2023 Portfolio in Review

As of Q2 2023, BNP Paribas Financial Markets held 4,079 positions worth $80B, up 12% from $71.4B the previous quarter. Its ten largest holdings account for 21% of the portfolio.

BNP Paribas Financial Markets's Q2 2023 filing shows 263 new, 1,328 increased, 1,932 reduced and 164 closed positions. Its largest new stake was Direxion NASDAQ-100 Equal Weighted Index ETF: 200,000 shares worth $15.4M. The largest sale was Invesco QQQ Trust, an estimated $643M.

By sector, the portfolio is most concentrated in Technology at 14% of assets, up from 13% a quarter earlier, followed by Consumer Discretionary and Healthcare.

  • BNP Paribas Financial Markets's largest Q2 2023 buy was Direxion NASDAQ-100 Equal Weighted Index ETF: 200,000 shares worth $15.4M.
  • BNP Paribas Financial Markets added most to Alibaba in Q2 2023, an estimated $1.52B increase.
  • BNP Paribas Financial Markets's biggest Q2 2023 reduction was Invesco QQQ Trust, cutting an estimated $643M.
  • BNP Paribas Financial Markets fully exited iShares Russell Mid-Cap Growth ETF in Q2 2023, selling an estimated $35.8M.
  • BNP Paribas Financial Markets's ten largest holdings make up 21% of its $80B portfolio in Q2 2023.
  • BNP Paribas Financial Markets opened 263 new positions and closed 164 in Q2 2023.
  • BNP Paribas Financial Markets's portfolio value rose 12% quarter-over-quarter to $80B.

Based on BNP Paribas Financial Markets's 13F filing for Q2 2023, filed 9 Aug 2023.